TuHURA Biosciences (HURA)
Develops immunotherapies aimed at overcoming resistance to cancer treatment.
$2.08
At close+0.05 (+2.46%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions89 holders · as of Mar 31, 2026 | 14.92% | 9.51M shares | |
| Insiders1 holder · as of May 29, 2026 | 3.41% | 2.17M shares | |
| Strategic holders1 holder · as of Feb 17, 2026 | 9.51% | 6.06M shares | |
| Otherremainder | 72.16% | 45.98M shares |
63.73M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
89 holders · 9.51M shares · 31 new positions · 68 increased · 9 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.45M | 3.84% | +883.9K | May 13, 2026 |
| Vanguard Capital Management LLC | 2.07M | 3.25% | +2.07Mnew | May 15, 2026 |
| Geode Capital Management, LLC | 986.9K | 1.55% | +324.4K | May 15, 2026 |
| AQR Capital Management LLC | 607.2K | 0.95% | +590.7K | May 15, 2026 |
| State Street Corp | 512.9K | 0.80% | +223.8K | May 15, 2026 |
| Northern Trust Corp | 298.2K | 0.47% | +106.6K | May 14, 2026 |
| Vanguard Fiduciary Trust Co | 287.1K | 0.45% | +287.1Knew | May 8, 2026 |
| Vanguard Portfolio Management LLC | 253.6K | 0.40% | +253.6Knew | May 8, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vijay Patel | 26.70% | 12.35M | 13D | Oct 25, 2024 ↗ |
| Highbridge Capital Management, LLC | 9.10% | 6.06M | 13G | Feb 17, 2026 ↗ |
| CA Patel F&F Investments, LLC | 6.10% | 2.57M | 13G | Oct 25, 2024 ↗ |
| KP Biotech Group LLC | 6.10% | 2.57M | 13G | Oct 25, 2024 ↗ |
| Charles S. Theofilos, M.D. | 5.90% | 2.51M | 13G | Oct 25, 2024 ↗ |
| Samir Patel | 5.80% | 2.47M | 13G | Oct 25, 2024 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
